Phathom制药 PHAT 深 沪
等待开盘 02-07 09:30:00 美东时间
12.57
+0.160
+1.29%
华盛通- 最 高18.31
- 今 开12.82
- 成交量 94.47万股
- 最 低 12.20
- 昨 收 12.41
- 总市值 49.11万
- 52周最高 18.31
- 市盈率 静 --
- 换手率 2417.81%
- 52周最低 0.00
- 委 比 27.43%
- 总股本 3.91万
- 历史最高 18.31
- 量 比 1.07
- 振 幅 49.23%
- 历史最低 0.00
- 每 手 1
- 风险率 4.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Phathom's Early Numbers Show Sales Strength, Eyes 2026 Profitability
Phathom Pharmaceuticals (NASDAQ: PHAT) reported Q4 sales of $57-$58 million, updated FY2025 revenue guidance to $174.5-$175.5 million.
01-08 21:49
Why AZZ Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of AZZ Inc (NYSE:AZZ) rose in pre-market trading after the company repor...
01-08 17:25
Phathom Pharmaceuticals Expects Q4 Net Revenues Of ~$57M-$58M And FY25 Net Revenues Of ~$174.5M-$175.5M
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced certain preliminary unaudited
01-08 05:06
报道：欧盟对越南热轧钢进口征收12.1%反倾销税
据报道，欧盟委员会对越南热轧钢进口征收12.1%反倾销税，当前越南钢铁行业正着力开拓欧洲市场，在此背景下，欧盟委员会出台了上述征税措施。 据悉，该决议豁免了和发集团（Hoa Phat Group）生产的相关产品。 据报道，欧盟同时对源自日本和埃及的（同类）进口产品征收了反倾销税。 美国已对源自越南及其他国家的冷轧钢进口征收反倾销税，征税期为2024年7月至2025年6月。 新浪合作大平台期货开户 安全快捷有保障 海量资讯、精准解读，尽在新浪财经APP 责任编辑：陈钰嘉
2025-09-28 09:09
大明国际高层代表团赴越南考察交流，深化区域合作布局
2025年6月22日至29日，大明国际董事会主席周克明率高级代表团赴越南进行商务访问。代表团成员包括总裁助理张俊、集团大项目部总经理钱增、进出口副总王旭明及部长...
2025-07-01 16:26
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Phathom Pharmaceuticals granted inducement awards to Anne Marie Cook, including stock options and performance stock units, as part of her employment as Chief Legal Officer. The awards vest over time and are tied to financial goals and continued service.
2025-06-23 20:15
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
Phathom Pharmaceuticals appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary, bringing extensive legal and leadership experience to support the company's growth in gastrointestinal disease treatments.
2025-06-23 11:59
Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
Phathom Pharmaceuticals announced the FDA's approval of its Citizen Petition, extending the exclusivity of VOQUEZNA to May 3, 2032, and recognizing the 10-year New Chemical Entity exclusivity.
2025-06-06 16:27
凯雷Q4重仓押注StandardAero 建仓中国自动驾驶公司文远知行、小马智行
根据美国证券交易委员会(SEC)披露，全球另类资产管理巨头凯雷(CARLYLE GROUP INC)递交了截止至2024年12月31日的第四季度持仓报告(13F)。 据统计，凯雷第四季度持仓总市值为41.5亿美元，上一季度总市值为9.5亿美元，环比大幅增长近40%。凯雷在第四季度的美股投资组合中新增6只个股，增持了2只个股，减持了5只个股，清仓5只个股。其中前十大持仓标的占总市值的99.16%。 在前十大重仓股中，StandardAero(SARO.US)位列第一，持仓约667.6万股，持仓市值约38.67亿美元，占投资组合比例高达91.09%，为凯雷本季度新增标的。 据了解，Standard...
2025-02-14 17:12
Needham Reiterates Buy on Phathom Pharmaceuticals, Maintains $26 Price Target
Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.
2024-09-07 01:14
